Advocacy

PSOH monitors state legislation and regulations that impact cancer care on behalf of its members and its members' patients. The Society has commented on a number of bills before the Legislature and provided testimony at a hearing for off-label prescribing. Below are more recent examples:

• Substituting generic drugs without physician permission for biosimilars: In July 2011, PSOH wrote to the Pennsylvania Department of Health seeking clarification to the state law that permits pharmacists to substitute generic drugs without physician permission. The objective was to see if the law pertains to biosimilars. Read DOH's response - August 10, 2011 (PDF)
• Letter to Gov. Corbett regarding hydraulic fracturing - October 4, 2011 (PDF)
• Letter to the Pennsylvania Department of Public Welfare regarding concerns over restriction to access of cancer medicines - October 26, 2011 (PDF)
• Letter to U.S. Senator Pat Toomey regarding his role with the Congressional Super Committee - October 12, 2011

Related material:

View a list of recent cancer-related state bills